Mestastop Solutions

I’m seeking a dynamic co-founder to join our pioneering startup, Mestastop Solutions. We’re innovatively addressing cancer treatment by focusing on delaying metastasis, the cause of 90% of cancer deaths. Leveraging patient clinical data and AI, we have patented three platforms that identify first-in-class targets and 100% metastasis inhibiting molecules. We offer a unique bedside-to-bench strategy, setting us apart from competitors in the solid tumours realm like Hibercell, Ona Therapeutics, Volastara, Recursion and Hummingbird Biosciences. We have already dedicated 7 years and $2M in intensive R&D securing US and India patents with regulatory approval for our inaugural Indian clinical trial. Our business model involves B2B outlicensing of our molecules and platforms, involving upfront payments, milestone-based earnings, and royalty payments. We are seeking an individual who can bring unique skills or innovative insights that can complement our existing strengths and help propel our growth

Mestastop is innovatively tackling cancer by focusing on delaying metastasis, the cause of 90% of cancer deaths. Our approach decouples cell proliferation from metastasis using patient translational data and AI, differing from the traditional anti-proliferative treatments. We're on our way to phase II clinical trials, targeting a revolutionary change in cancer treatment.

Our solution tackles the life-threatening problem of metastasis. Current drugs only briefly extend survival—our innovative platforms aim to dramatically increase that by a minimum of 24 months. Utilizing unique targets and repurposed drugs, we're transforming patient outcomes through advancements in anti-metastatic treatments and companion diagnostics.